Laporan Laba Rugi (TTM)
Laporan Laba Rugi JW Pharmaceutical Corporation - Preferred Stock menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 516,529 | 547,336 | 560,407 | 569,978 | 581,827 | 606,585 | 620,832 | 639,806 | 660,661 | 684,351 | 701,393 | 722,312 | 736,668 | 748,527 | 755,737 | 742,090 | 736,543 | 719,376 | 724,018 | 742,847 |
| Change (%) | 5.96 | 2.39 | 1.71 | 2.08 | 4.26 | 2.35 | 3.06 | 3.26 | 3.59 | 2.49 | 2.98 | 1.99 | 1.61 | 0.96 | -1.81 | -0.75 | -2.33 | 0.65 | 2.60 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 368,301 | 369,810 | 367,205 | 360,118 | 359,581 | 372,209 | 381,077 | 390,548 | 395,943 | 396,397 | 401,974 | 404,477 | 406,556 | 412,984 | 412,916 | 411,745 | 401,807 | 395,878 | 399,371 | 398,659 |
| Change (%) | 0.41 | -0.70 | -1.93 | -0.15 | 3.51 | 2.38 | 2.49 | 1.38 | 0.11 | 1.41 | 0.62 | 0.51 | 1.58 | -0.02 | -0.28 | -2.41 | -1.48 | 0.88 | -0.18 | |
| % of Revenue | 71.30 | 67.57 | 65.52 | 63.18 | 61.80 | 61.36 | 61.38 | 61.04 | 59.93 | 57.92 | 57.31 | 56.00 | 55.19 | 55.17 | 54.64 | 55.48 | 54.55 | 55.03 | 55.16 | 53.67 |
| Gross Operating Profit | 148,228 | 177,526 | 193,202 | 209,860 | 222,246 | 234,376 | 239,754 | 249,258 | 264,719 | 287,954 | 299,419 | 317,834 | 330,112 | 335,542 | 342,821 | 330,346 | 334,735 | 323,498 | 324,647 | 344,188 |
| Change (%) | 19.77 | 8.83 | 8.62 | 5.90 | 5.46 | 2.29 | 3.96 | 6.20 | 8.78 | 3.98 | 6.15 | 3.86 | 1.65 | 2.17 | -3.64 | 1.33 | -3.36 | 0.36 | 6.02 | |
| % of Revenue | 28.70 | 32.43 | 34.48 | 36.82 | 38.20 | 38.64 | 38.62 | 38.96 | 40.07 | 42.08 | 42.69 | 44.00 | 44.81 | 44.83 | 45.36 | 44.52 | 45.45 | 44.97 | 44.84 | 46.33 |
| SG&A | 158,290 | 155,905 | 162,051 | 172,804 | 176,948 | 183,645 | 183,461 | 185,239 | 194,086 | 193,728 | 197,326 | 200,738 | 202,026 | 205,240 | 206,970 | 202,707 | 202,540 | 204,528 | 206,833 | 209,720 |
| Change (%) | -1.51 | 3.94 | 6.64 | 2.40 | 3.78 | -0.10 | 0.97 | 4.78 | -0.18 | 1.86 | 1.73 | 0.64 | 1.59 | 0.84 | -2.06 | -0.08 | 0.98 | 1.13 | 1.40 | |
| % of Revenue | 30.64 | 28.48 | 28.92 | 30.32 | 30.41 | 30.28 | 29.55 | 28.95 | 29.38 | 28.31 | 28.13 | 27.79 | 27.42 | 27.42 | 27.39 | 27.32 | 27.50 | 28.43 | 28.57 | 28.23 |
| R&D | 22,341 | 22,943 | 22,653 | 21,680 | 22,478 | 19,884 | 21,490 | 22,424 | 25,914 | 33,736 | 34,471 | 36,842 | 36,230 | 33,671 | 33,428 | 34,503 | 34,814 | 36,237 | 39,322 | 42,646 |
| Change (%) | 2.70 | -1.27 | -4.29 | 3.68 | -11.54 | 8.08 | 4.34 | 15.57 | 30.19 | 2.18 | 6.88 | -1.66 | -7.06 | -0.72 | 3.22 | 0.90 | 4.09 | 8.51 | 8.45 | |
| % of Revenue | 4.33 | 4.19 | 4.04 | 3.80 | 3.86 | 3.28 | 3.46 | 3.50 | 3.92 | 4.93 | 4.91 | 5.10 | 4.92 | 4.50 | 4.42 | 4.65 | 4.73 | 5.04 | 5.43 | 5.74 |
| OpEx | 548,932 | 548,659 | 551,909 | 554,602 | 559,007 | 575,737 | 586,028 | 598,211 | 615,943 | 623,861 | 633,771 | 642,058 | 644,812 | 651,896 | 653,314 | 648,954 | 639,161 | 636,643 | 645,526 | 651,025 |
| Change (%) | -0.05 | 0.59 | 0.49 | 0.79 | 2.99 | 1.79 | 2.08 | 2.96 | 1.29 | 1.59 | 1.31 | 0.43 | 1.10 | 0.22 | -0.67 | -1.51 | -0.39 | 1.40 | 0.85 | |
| % of Revenue | 106.27 | 100.24 | 98.48 | 97.30 | 96.08 | 94.91 | 94.39 | 93.50 | 93.23 | 91.16 | 90.36 | 88.89 | 87.53 | 87.09 | 86.45 | 87.45 | 86.78 | 88.50 | 89.16 | 87.64 |
| Operating Income | -32,403 | -1,323 | 8,498 | 15,375 | 22,820 | 30,848 | 34,804 | 41,595 | 44,719 | 60,490 | 67,623 | 80,254 | 91,856 | 96,631 | 102,423 | 93,136 | 97,382 | 82,733 | 78,493 | 91,822 |
| Change (%) | -95.92 | -742.30 | 80.94 | 48.42 | 35.18 | 12.82 | 19.51 | 7.51 | 35.27 | 11.79 | 18.68 | 14.46 | 5.20 | 5.99 | -9.07 | 4.56 | -15.04 | -5.12 | 16.98 | |
| % of Revenue | -6.27 | -0.24 | 1.52 | 2.70 | 3.92 | 5.09 | 5.61 | 6.50 | 6.77 | 8.84 | 9.64 | 11.11 | 12.47 | 12.91 | 13.55 | 12.55 | 13.22 | 11.50 | 10.84 | 12.36 |
| Interest Expense | -7,705 | -7,587 | -6,969 | -5,916 | -6,816 | -7,337 | -8,150 | -9,562 | -10,524 | -9,387 | -9,421 | -10,699 | -11,402 | -12,562 | -10,165 | -6,112 | -5,134 | -10,033 | -10,033 | -10,033 |
| Change (%) | -1.53 | -8.15 | -15.11 | 15.21 | 7.64 | 11.08 | 17.33 | 10.06 | -10.80 | 0.37 | 13.56 | 6.57 | 10.17 | -19.08 | -39.87 | -16.00 | 95.42 | -0.00 | -0.00 | |
| % of Revenue | -1.49 | -1.39 | -1.24 | -1.04 | -1.17 | -1.21 | -1.31 | -1.49 | -1.59 | -1.37 | -1.34 | -1.48 | -1.55 | -1.68 | -1.35 | -0.82 | -0.70 | -1.39 | -1.39 | -1.35 |
| Net Income | -31,512 | -15,241 | -8,469 | -3,329 | -1,190 | -968 | 4,584 | 8,930 | 12,130 | 31,892 | 37,834 | 51,278 | 25,076 | 37,006 | 41,568 | 35,653 | 73,410 | 65,040 | 62,423 | 52,047 |
| Change (%) | -51.63 | -44.43 | -60.69 | -64.25 | -18.68 | -573.62 | 94.81 | 35.84 | 162.91 | 18.63 | 35.53 | -51.10 | 47.58 | 12.33 | -14.23 | 105.90 | -11.40 | -4.02 | -16.62 | |
| % of Revenue | -6.10 | -2.78 | -1.51 | -0.58 | -0.20 | -0.16 | 0.74 | 1.40 | 1.84 | 4.66 | 5.39 | 7.10 | 3.40 | 4.94 | 5.50 | 4.80 | 9.97 | 9.04 | 8.62 | 7.01 |
Source: Capital IQ
